Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InnovAge HoldingINNV +1.51%57 Debt-to-Equity is 0.37 as of Jun. 2026, which is 5% below its 10-year median of 0.39. GuruFocus rates INNV with a GF Score™ of 57/100 and a GF Value™ of $6.75 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 560 Healthcare Providers & Services companies, InnovAge Holding ranks better than 52.14% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for InnovAge Holding's Debt-to-Equity or its related term are showing as below:
INNV'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.25 Med: 0.39 Max: 2.63
Current: 0.37
During the past 8 years, the highest Debt-to-Equity Ratio of InnovAge Holding was 2.63. The lowest was 0.25. And the median was 0.39.
INNV's Debt-to-Equity is ranked better than 52.14% of 560
companies
in the Healthcare Providers & Services industry
Industry Median: 0.43
vs INNV: 0.37
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
InnovAge Holding Debt-to-Equity Related Terms
InnovAge Holding Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for InnovAge Holding's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INNV vs HCSG, ARDT, AGL: Debt-to-Equity Comparison
For the Medical Care Facilities subindustry, InnovAge Holding's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InnovAge Holding Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, InnovAge Holding's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where InnovAge Holding's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnovAge Holding (INNV) has a Debt-to-Equity of 0.37 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on InnovAge Holding and its competitors. This is near median its historical median of 0.39. Over the past decade, InnovAge Holding's Debt-to-Equity has ranged from 0.25 to 2.63. According to the industry distribution chart, InnovAge Holding ranks #268 out of 560 companies in the Healthcare Providers & Services industry, placing it in the top 47.9%.
Is InnovAge Holding's Debt-to-Equity too high?
InnovAge Holding's current Debt-to-Equity of 0.37 is near median its 10-year median of 0.39. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 2.63. The Healthcare Providers & Services industry median Debt-to-Equity is 0.43. InnovAge Holding's value of 0.37 is 14% below this industry median. Based on the distribution chart, InnovAge Holding ranks #268 out of 560 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, InnovAge Holding has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnovAge Holding's Debt-to-Equity compare to HCSG and ARDT?
According to the Healthcare Providers & Services industry distribution chart, InnovAge Holding ranks #268 out of 560 companies for Debt-to-Equity. This puts InnovAge Holding in the upper half of its industry. The industry median Debt-to-Equity is 0.43. InnovAge Holding's value of 0.37 is 14% below this benchmark. Historically, InnovAge Holding's own Debt-to-Equity has ranged from 0.25 to 2.63 over the past decade. While the company's 10-year median is 0.39 vs. the industry median of 0.43, InnovAge Holding has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.43, based on 560 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InnovAge Holding's current Debt-to-Equity of 0.37 is 14% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on InnovAge Holding and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InnovAge Holding's current Debt-to-Equity is 0.37, which is near median its own 10-year median of 0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnovAge Holding stock overvalued right now?
Based on GuruFocus' analysis, InnovAge Holding (INNV) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.75, compared to a current price of $10.76 — trading 59.4% above its estimated fair value. The current Debt-to-Equity is 0.37, which is near median its 10-year median of 0.39 and 14% below the Healthcare Providers & Services industry median of 0.43. InnovAge Holding's overall GF Score™ is 57/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For InnovAge Holding (INNV), the current Debt-to-Equity is 0.37 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InnovAge Holding (INNV) Overvalued in 2026?
Based on GuruFocus' analysis, InnovAge Holding stock appears to be overvalued.
The current stock price of $10.76 is trading 59.4% above its estimated GF Value™ of $6.75.
GuruFocus considers InnovAge Holding to be Significantly Overvalued.
Key valuation signals for INNV:
Debt-to-Equity: 0.37 (near median its 10-year median of 0.39)
GF Value™: $6.75 vs. price of $10.76 (59.4% above fair value)
Industry Position: 14% below the Healthcare Providers & Services median (#268 of 560)
No single metric tells the full story. See the INNV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.
57GF Score
Get the complete analysis for INNV
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INNV has been successfully added to your 
